Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
La Revue De Medecine Interne|November 9, 2013
[Therapeutic update in rheumatoid arthritis]T Lequerré, G Avenel, O VittecoqRheumatology (Oxford, England)|December 21, 2006
A cryopyrin-associated periodic syndrome with joint destructionT Lequerré, O Vittecoq, P Saugier-Veber, et al.Clinical Rheumatology|June 11, 2020
The impact of an in-department pharmacist on the prevention of drug iatrogenesis in a rheumatology departmentA Soubieux, C Chenailler, C Lattard, et al.Arthritis Research & Therapy|May 27, 2017
Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritisC Derambure, G Dzangue-Tchoupou, C Berard, et al.Journal of Clinical Immunology|July 1, 2008
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patientsH Bacquet-Deschryver, F Jouen, M Quillard, et al.Rheumatology (Oxford, England)|August 11, 2006
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximabT Lequerré, F Jouen, M Brazier, et al.Annals of the Rheumatic Diseases|October 20, 2007
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in FranceT Lequerré, P Quartier, D Rosellini, et al.Arthritis Care & Research|November 15, 2011
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab RegistryX Puéchal, J E Gottenberg, J M Berthelot, et al.Pageof 1